Explore more publications!
Health Update Bahamas
Submit Press Release

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 24, 2025

Newsmatics Brings AI-Powered News Platforms to Czech Republic’s AI Festival for Everyone
September 24, 2025

Newsmatics Brings AI-Powered News Platforms to Czech Republic’s AI Festival for Everyone

Indeterminate EIN Presswire
Range Impact Announces $550,000 Capital Raise
September 24, 2025

Range Impact Announces $550,000 Capital Raise

Indeterminate GlobeNewswire
Verano to Report Third Quarter 2025 Financial Results on October 29, 2025
September 24, 2025

Verano to Report Third Quarter 2025 Financial Results on October 29, 2025

Indeterminate GlobeNewswire
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
September 24, 2025

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Indeterminate GlobeNewswire
Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025
September 24, 2025

Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025

Indeterminate GlobeNewswire
uniQure Announces $200 Million Proposed Public Offering
September 24, 2025

uniQure Announces $200 Million Proposed Public Offering

Indeterminate GlobeNewswire
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
September 24, 2025

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

Indeterminate GlobeNewswire
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck
September 24, 2025

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

Indeterminate GlobeNewswire
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
September 24, 2025

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association

Indeterminate GlobeNewswire
Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi
September 24, 2025

Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi

Indeterminate GlobeNewswire
Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors
September 24, 2025

Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors

Indeterminate GlobeNewswire
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
September 24, 2025

Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

Indeterminate GlobeNewswire
Inventiva to Host Analyst and Investor Event on October 8, 2025
September 24, 2025

Inventiva to Host Analyst and Investor Event on October 8, 2025

Indeterminate GlobeNewswire
Inventiva organise un événement analystes et investisseurs le 8 octobre 2025
September 24, 2025

Inventiva organise un événement analystes et investisseurs le 8 octobre 2025

Indeterminate GlobeNewswire
SoCalBio Investor & Partnership Conference to Feature Keynotes from SetPoint CEO Murthy Simhambhatla, PhD, and MedTech Industry Deal-Maker Ray Cohen
September 24, 2025

SoCalBio Investor & Partnership Conference to Feature Keynotes from SetPoint CEO Murthy Simhambhatla, PhD, and MedTech Industry Deal-Maker Ray Cohen

Indeterminate GlobeNewswire
New Report Offers Recommendations to Advance Brain Capital for Economic and Workforce Growth
September 24, 2025

New Report Offers Recommendations to Advance Brain Capital for Economic and Workforce Growth

Indeterminate GlobeNewswire
Unity Consortium Announces Bold Commitment to Empower Teen Vaccine Ambassadors at Clinton Global Initiative Meeting
September 24, 2025

Unity Consortium Announces Bold Commitment to Empower Teen Vaccine Ambassadors at Clinton Global Initiative Meeting

Indeterminate GlobeNewswire
Global Neuroprotection Devices Market to Register Growth at a CAGR of ~7% by 2032 | DelveInsight
September 24, 2025

Global Neuroprotection Devices Market to Register Growth at a CAGR of ~7% by 2032 | DelveInsight

Indeterminate GlobeNewswire
Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on a like-for-like basis, mainly due to the decline in activity in France
September 24, 2025

Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on a like-for-like basis, mainly due to the decline in activity in France

Indeterminate GlobeNewswire
Guerbet : Résultats semestriels 2025 : Chiffre d’affaires du 1er semestre : 387,8 M€, en retrait de 5,4% à TCC et périmètre comparable principalement en lien avec la baisse d’activité en France
September 24, 2025

Guerbet : Résultats semestriels 2025 : Chiffre d’affaires du 1er semestre : 387,8 M€, en retrait de 5,4% à TCC et périmètre comparable principalement en lien avec la baisse d’activité en France

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions